Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach.
Dimitrakov
Jordan D
JD
Harvard Urological Diseases Research Center, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA. Jordan.Dimitrakov@childrens.harvard.edu
Kaplan
Steven A
SA
Kroenke
Kurt
K
Jackson
Jeffrey L
JL
Freeman
Michael R
MR
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002908:Chronic Disease; D004965:Estrogen Antagonists / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D008297:Male; D008613:Mepartricin / Q000627:therapeutic use; D008875:Middle Aged; D017699:Pelvic Pain / Q000175:diagnosis / Q000188:drug therapy*; D010426:Pentosan Sulfuric Polyester / Q000627:therapeutic use; D011472:Prostatitis / Q000175:diagnosis / Q000188:drug therapy*; D013450:Sulfones / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004965:Estrogen Antagonists; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib; D008613:Mepartricin; D010426:Pentosan Sulfuric Polyester